The following table contains subtest information from the standardization sample (N = 540), described in the manual.
Picture Naming 9.6 (0.7) 9.4 (1.1) 9.4 (0.9) 9.7 (0.5) 9.6 (0.7) 9.1 (1.0) 
General Issues in Interpreting Performance on the RBANS
Certain index scores can be significantly affected by relatively minor changes on certain subtests. This is particularly true for scores in the normal average range for young patients. Because the range is narrow, particularly in young normals on measures such as Picture Naming, Word List Recognition, and Figure Copy , a few points on any of these can result in a rapid drop of the associated index score. It is certainly worthwhile to routinely examine the subtest scores underlying index score performance for additional interpretive information, particularly if the index score appears to be unusually low in the context of a patient's presentation or other test scores.
Certain subtests have range restrictions and a skewed distribution of scores in normals, caution should be exercised in attempting to interpret individual patient performance on the basis of the normal mean and standard deviation for these subtests.The subtest data be used primarily to interpret index score performance, and not as stand-alone measures.
Additional Information on Test-Retest Interpretation
One of the most unique features of the RBANS is that it has equivalent alternate forms, which allows for retesting patients without the confounding of significant content-related practice effects. There are a variety of ways of interpreting neurocognitive change scores, and a complete discussion of this topic is beyond the bounds of this handout.
On a practical basis, it seems unlikely that most clinicians will be interested in plugging test scores into regression 2 equations in order to compute the statistical probability of various score changes. It is often more useful to have a good understanding of the distribution of change scores for a particular test, and to use that information in clinical decision-making regarding the etiology of the observed change. It is always best, of course, to avoid relying upon a single source of information to conclude that there has been a significant change in a patient's neurocognitive status, and the prudent clinician will consider multiple sources of information in reaching such a conclusion. Change distributions for the two separate samples were comparable, and therefore the samples were combined for this purpose. Test-retest intervals ranged from 1 to 134 days, and there was no apparent effect of time on retest performance over this interval range.
Data
The Average Total Scale Change Score was Less Than 1 Point Table 2 indicates the percentage of the combined sample that obtained a change score within each interval. For example, 4.6% of the sample had a increase in their Total scaled score on the second testing between 16 and 20 points (inclusive). Less than 7% of the sample declined by more than 10 points on the second testing, and less than 21% of the sample declined by more than 5 points-two bits of data that are clinically relevant. 
A Discussion of Cortical-Subcortical Deviation Scores
The distinction between "cortical" and "subcortical" dementias is commonly understood to reflect different patterns of neurocognitive impairment, associated with different patterns of neuropathology. Although this topic cannot be reviewed in detail here, Alzheimer's disease is usually considered the prototypical "cortical" dementia, with impairments of memory and language as dominant features. In contrast, attentional and certain visuospatial functions may be more prominently impaired in disorders like Huntington's disease, Parkinson's disease, ischemic cerebrovascular disease, and progressive supranuclear palsy, all of which are characterized by greater early pathologic involvement of subcortical white matter and/or subcortical nuclei (e.g., the basal ganglia). Randolph et al. (1998) This analysis has also been applied in attempting to differentiate AD patients from patients with ischemic cerebrovascular disease, diagnosed according to State of California criteria (Fink et al., 1998) Figure 4 , the use of this Cortical-Subcortical deviation score may have some diagnostic and/or heuristic value, although additional investigation is clearly needed.
Updated Clinical Validity Information
The Concussion- Moser and Schatz (2002) reported that the RBANS was effective in detecting the effects of a recent (< one week) concussion in youth athletes.
Schizophrenia-In a pair of articles published in the American Journal of Psychiatry, Gold and colleagues Hobart et al., 1999) examined RBANS and WAIS-3/WMS-3 data from approximately 150 patients with schizophrenia. They concluded that the RBANS was highly sensitive to the neurocognitive impairments associated with schizophrenia, demonstrated convergent validity via strong correlations with specific WAIS-3/WMS-3 indices, and was minimally correlated with positive psychiatric symptoms (i.e., BPRS scores), but was strongly correlated with employment outcome. The authors concluded that the RBANS appeared to meet criteria for use as a neurocognitive screening instrument and outcome measurement tool in schizophrenia. Wilk et al. (2002) examined 181 patients with schizophrenia on the alternate forms (A and B) of the RBANS, with test-retest intervals ranging from 1-134 days. The intraclass correlation coefficient for the total scale score was .84. The authors concluded that retest measurement error for the RBANS was comparable to that of WAIS-3/WMS-3, suggesting that the brevity of the RBANS in comparison to these much longer tests does not result in a marked decrease in test-retest stability. Smigielski et al. (2001) compared RBANS scores in patients with traumatic brain injury to other established neuropsychological measures. They concluded that the RBANS demonstrated satisfactory concurrent validity with these measures, and appeared to be sensitive to the impairments demonstrated by patients with moderate-severe TBI. They suggest that the RBANS may be a useful tool in the early psychometric evaluation of TBI.
Test-retest reliability

Traumatic brain injury
Stroke Hoye et al. (2000) used the RBANS in the evaluation of stroke patients during inpatient rehabilitation.
They found that the RBANS index scores were related to functional outcome at the end of rehabilitation.
This finding was similar to an earlier study by Larson et al. (1999) .
